15 results for “maternal substance use disorder”
Finding into death of Baby W
Female·Intrauterine pneumonia and meconium aspiration complicating intrauterine growth restriction in the setting of maternal amphetamine use
Baby W was born at 37+5 weeks in an ambulance and died at Bendigo Hospital from intrauterine pneumonia and meconium aspiration secondary to intrauterine growth restriction related to maternal amphetamine use. The mother had known substance abuse, prior child protection involvement, and tested positive for amphetamine during pregnancy (October and December 2013), yet did not engage with maternity services until 20 December, just 3 weeks before delivery. Critical failures included: absence of systematic substance use screening during early pregnancy, lack of specialist addiction medicine consultation despite known daily amphetamine use, non-attendance at appointments without assertive follow-up, poor information-sharing between child protection and maternity services due to confidentiality barriers, and absence of supportive outreach when the mother disengaged. Clinicians prioritised maintaining engagement over providing specialist drug support, fearing referral might deter the mother from care. Better outcomes required: early risk assessment, mandatory referral to specialist pregnancy drug services, proactive home outreach, information-sharing protocols for at-risk pregnancies, and multidisciplinary case conferencing combining child protection, obstetrics, and addiction medicine.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.